Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19

Abstract

Letters18 August 2020Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19FREEHuilan Zhang, PhD, Cong-Yi Wang, PhD, Peng Zhou, PhD, Huihui Yue, MD, and Ronghui Du, MDHuilan Zhang, PhDCenter for Biomedical Research, NHC Key Laboratory of Respiratory Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China (H.Z., C.W., H.Y.)Search for more papers by this author, Cong-Yi Wang, PhDCenter for Biomedical Research, NHC Key Laboratory of Respiratory Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China (H.Z., C.W., H.Y.)Search for more papers by this author, Peng Zhou, PhDCAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China (P.Z.)Search for more papers by this author, Huihui Yue, MDCenter for Biomedical Research, NHC Key Laboratory of Respiratory Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China (H.Z., C.W., H.Y.)Search for more papers by this author, and Ronghui Du, MDWuhan Pulmonary Hospital, Wuhan, China (R.D.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/L20-0895 SectionsAboutVisual AbstractPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:We believe that the resolution of the issues noted by Dr. Narasaraju would provide valuable information to help understand the pathogenesis and pathologic mechanisms underlying COVID-19. Here, we respond to the 3 points that he raised.First, Dr. Narasaraju noticed the gathering of neutrophils evidenced by the elongated nuclear staining in panel A-1 of Figure 2 of our case report. To address this concern, our team further examined lung sections for neutrophils (MPO+) and macrophages (CD68+) by immunostaining. We found that macrophages were the predominant infiltrating cells; neutrophils accounted for merely a small proportion, which is consistent with previous studies (1, 2). Given that neutrophil extracellular NETs—which are critical for the bactericidal function of neutrophils—are a specialized molecular structure formed by dying neutrophils, it is therefore plausible that massive neutrophil infiltration would be obvious upon the occurrence of severe secondary bacterial infection.Second, we do not exclude the possibility that patients with COVID-19 could exhibit lung hemorrhagic changes. However, this was not the case in our patient, which could be related to the disease course and disease severity of patients with COVID-19. More autopsy evidence and clinical information are therefore needed to confirm the correlation between hemorrhagic pathologic changes and COVID-19, such as whether patients received extracorporeal membrane oxygenation before death or had such comorbidities as severe coagulation dysfunction.Finally, we co-stained severe acute respiratory syndrome coronavirus 2 with CD3+ (T-cell marker), CD68+ (macrophage marker), and MPO+ (neutrophil marker) by immunofluorescence. The results showed that it did involve several immune cells, including T cells, macrophages, and a few neutrophils.We hope that our clarifications have shed more light on the mechanisms and pathologic processes of COVID-19.References1. Luo W, Yu H, Gou J, et al. Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19). Preprints. Preprint posted online 27 February 2020. Google Scholar2. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420-422. [PMID: 32085846] doi:10.1016/S2213-2600(20)30076-X CrossrefMedlineGoogle Scholar Comments 0 Comments Sign In to Submit A Comment Author, Article, and Disclosure InformationAuthors: Huilan Zhang, PhD; Cong-Yi Wang, PhD; Peng Zhou, PhD; Huihui Yue, MD; Ronghui Du, MDAffiliations: Center for Biomedical Research, NHC Key Laboratory of Respiratory Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China (H.Z., C.W., H.Y.)CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China (P.Z.)Wuhan Pulmonary Hospital, Wuhan, China (R.D.)Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M20-0533. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoHistopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19 Huilan Zhang , Peng Zhou , Yanqiu Wei , Huihui Yue , Yi Wang , Ming Hu , Shu Zhang , Tanze Cao , Chengqing Yang , Ming Li , Guangyun Guo , Xianxiang Chen , Ying Chen , Mei Lei , Huiguo Liu , Jianping Zhao , Peng Peng , Cong-Yi Wang , and Ronghui Du Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19 Teluguakula Narasaraju Metrics Cited byAdvancement in Beneficial Effects of AVE 0991: A Brief ReviewAdvances of presepsin in sepsis-associated ARDSTargeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse modelEvidence of SARS-CoV-2 infection in postmortem lung, kidney, and liver samples, revealing cellular targets involved in COVID-19 pathogenesisNew insights into extracellular and intracellular redox status in COVID-19 patientsCOVID-19Effectiveness of a respiratory rehabilitation program including an inspiration training device versus traditional respiratory rehabilitation: a randomized controlled trialAn overview of prognostic value of neurologic and cardiac biomarkers in patients with COVID-19 sequelaePulmonary fibrosis in patients with COVID-19: A retrospective studyThe potential of heparin-induced extracorporeal LDL/fibrinogen precipitation (H.E.L.P.)-apheresis for patients with severe acute or chronic COVID-19Thrombotic events in children and adolescent patients with SARS-CoV-2 infection: a systematic review with meta-analysis on incidence and managementVitamin D Regulation of Immune FunctionThe Fatal Circle of NETs and NET-Associated DAMPs Contributing to Organ DysfunctionIvermectin: Evaluation of Efficacy and Safety in COVID-19Severe acute respiratory syndrome coronavirus 2 causes lung inflammation and injurySARS-CoV-2-related lung pathology: macroscopic and histologic features and their clinical implicationsPlacental pathology concerning sudden foetal demise in SARS-CoV-2 positive asymptomatic pregnant femaleHistopathological findings and clinicopathologic correlation in COVID-19: a systematic reviewProteomic characteristics of bronchoalveolar lavage fluid in critical COVID‐19 patientsA Fragile Balance: Does Neutrophil Extracellular Trap Formation Drive Pulmonary Disease Progression?Pathophysiology of infection with SARS‐CoV ‐2— What is known and what remains a mysteryRelating Ventilatory Support and Drug Treatment Strategies to the Fundamental Pathophysiology in COVID-19 IllnessMicro-RNAs in the regulation of immune response against SARS CoV-2 and other viral infectionsA double edged-sword - The Complement System during SARS-CoV-2 infectionBacterial Superinfections Among Persons With Coronavirus Disease 2019: A Comprehensive Review of Data From Postmortem StudiesFrequency and characterization of ancillary chest CT findings in COVID-19 pneumoniaThe Reversed Halo Sign and COVID-19: Possible Histopathological Mechanisms Related to the Appearance of This Imaging FindingCOVID-19 Chest Computed Tomography to Stratify Severity and Disease Extension by Artificial Neural Network Computer-Aided DiagnosisSARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patientsIndirubin alleviates bleomycin-induced pulmonary fibrosis in mice by suppressing fibroblast to myofibroblast differentiationActivated macrophages are the main inflammatory cell in COVID-19 interstitial pneumonia infiltrates. Is it possible to show their metabolic activity and thus the grade of inflammatory burden with 18F-Fluorocholine PET/CT?Can hyperbaric oxygen safely serve as an anti-inflammatory treatment for COVID-19?The reversed halo sign: Considerations in the context of the COVID-19 pandemicCOVID-19 and Respiratory System DisordersAutopsy Findings and Venous Thromboembolism in Patients With COVID-19 A Prospective Cohort StudyDominic Wichmann, MD, Jan-Peter Sperhake, MD, Marc Lütgehetmann, MD, Stefan Steurer, MD, Carolin Edler, MD, Axel Heinemann, MD, Fabian Heinrich, Herbert Mushumba, MD, Inga Kniep, MD, Ann Sophie Schröder, MD, Christoph Burdelski, MD, Geraldine de Heer, MD, Axel Nierhaus, MD, Daniel Frings, MD, Susanne Pfefferle, MD, Heinrich Becker, MD, Hanns Bredereke-Wiedling, MD, Andreas de Weerth, MD, Hans-Richard Paschen, MD, Sara Sheikhzadeh-Eggers, MD, Axel Stang, MD, Stefan Schmiedel, MD, Carsten Bokemeyer, MD, Marylyn M. Addo, MD, PhD, Martin Aepfelbacher, MD, Klaus Püschel, MD, and Stefan Kluge, MDAlternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global PandemicProfiling European countries on COVID–19 prevalence and association with non–pharmaceutical interventionsComparative prevalence of COVID–19 in european countries: a time window at second wave17β-Estradiol, a potential ally to alleviate SARS-CoV-2 infection 18 August 2020Volume 173, Issue 4 Page: 324 Keywords Cells COVID-19 Disclosure Extracorporeal membrane oxygenation Immunofluorescence Lungs Neutrophils Pathogenesis Staining T cells ePublished: 18 August 2020 Issue Published: 18 August 2020 Copyright & PermissionsCopyright © 2020 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...

Topics & Concepts